

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 8.32845298 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 8.32845298 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.29971462 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.29971462 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.09246576 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.41081044 |
| 7 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.36005860 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.25771556 |
| 9 | endocrine pancreas development (GO:0031018) | 5.07218575 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.86490227 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82886630 |
| 12 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.82156877 |
| 13 | protein maturation by protein folding (GO:0022417) | 4.77960540 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.76710981 |
| 15 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.70134748 |
| 16 | positive regulation of nuclease activity (GO:0032075) | 4.58907165 |
| 17 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.55594927 |
| 18 | COPII vesicle coating (GO:0048208) | 4.49221064 |
| 19 | type B pancreatic cell development (GO:0003323) | 4.47396010 |
| 20 | positive regulation of histone deacetylation (GO:0031065) | 4.43667426 |
| 21 | negative regulation of bone resorption (GO:0045779) | 4.40271325 |
| 22 | detection of bacterium (GO:0016045) | 4.33039002 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.30513851 |
| 24 | regulation of nuclease activity (GO:0032069) | 4.27610219 |
| 25 | sequestering of metal ion (GO:0051238) | 4.26412875 |
| 26 | detection of other organism (GO:0098543) | 4.24154907 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 4.21427431 |
| 28 | peptide hormone processing (GO:0016486) | 4.19172606 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18511330 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 4.18511330 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18511330 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 4.18511330 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18511330 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18511330 |
| 35 | glandular epithelial cell development (GO:0002068) | 4.17556223 |
| 36 | protein retention in ER lumen (GO:0006621) | 4.15494856 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 4.00603633 |
| 38 | glandular epithelial cell differentiation (GO:0002067) | 3.97079017 |
| 39 | positive T cell selection (GO:0043368) | 3.93714794 |
| 40 | positive regulation of granulocyte differentiation (GO:0030854) | 3.91514226 |
| 41 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.90992299 |
| 42 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.79295371 |
| 43 | cellular response to unfolded protein (GO:0034620) | 3.77219388 |
| 44 | vesicle coating (GO:0006901) | 3.72628973 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.68708575 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.66821026 |
| 47 | germinal center formation (GO:0002467) | 3.65710561 |
| 48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.62698754 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.62642256 |
| 50 | ER-nucleus signaling pathway (GO:0006984) | 3.60807584 |
| 51 | cellular response to topologically incorrect protein (GO:0035967) | 3.58893717 |
| 52 | cellular extravasation (GO:0045123) | 3.54878421 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.54129533 |
| 54 | thymic T cell selection (GO:0045061) | 3.51999073 |
| 55 | response to peptidoglycan (GO:0032494) | 3.50105776 |
| 56 | adaptation of signaling pathway (GO:0023058) | 3.49748961 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.47741117 |
| 58 | exocrine pancreas development (GO:0031017) | 3.43919496 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.43722778 |
| 60 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.43215011 |
| 61 | positive regulation of insulin secretion (GO:0032024) | 3.40806590 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40076005 |
| 63 | negative regulation of bone remodeling (GO:0046851) | 3.39952163 |
| 64 | positive regulation of B cell differentiation (GO:0045579) | 3.39752033 |
| 65 | tolerance induction (GO:0002507) | 3.38343724 |
| 66 | neutrophil activation (GO:0042119) | 3.34155715 |
| 67 | signal peptide processing (GO:0006465) | 3.29645240 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29537169 |
| 69 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.29527002 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.28756180 |
| 71 | T cell selection (GO:0045058) | 3.27390420 |
| 72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27252136 |
| 73 | positive regulation of protein deacetylation (GO:0090312) | 3.27135355 |
| 74 | respiratory burst (GO:0045730) | 3.25678327 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 3.24990069 |
| 76 | cellular response to interleukin-15 (GO:0071350) | 3.24680002 |
| 77 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.21196107 |
| 78 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.19926201 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18061075 |
| 80 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16398658 |
| 81 | detection of external biotic stimulus (GO:0098581) | 3.15051834 |
| 82 | insulin secretion (GO:0030073) | 3.14562614 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 3.11038474 |
| 84 | negative regulation of cell killing (GO:0031342) | 3.10841508 |
| 85 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10841508 |
| 86 | regulation of granulocyte differentiation (GO:0030852) | 3.10712815 |
| 87 | response to type I interferon (GO:0034340) | 3.09764147 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.07888907 |
| 89 | type I interferon signaling pathway (GO:0060337) | 3.07496006 |
| 90 | cellular response to type I interferon (GO:0071357) | 3.07496006 |
| 91 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07398259 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.04219174 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 3.04105826 |
| 94 | response to endoplasmic reticulum stress (GO:0034976) | 3.03986197 |
| 95 | response to interleukin-15 (GO:0070672) | 3.03356386 |
| 96 | defense response to protozoan (GO:0042832) | 3.02510879 |
| 97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02410145 |
| 98 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.01310341 |
| 99 | regulation of tolerance induction (GO:0002643) | 2.99806886 |
| 100 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.99758702 |
| 101 | positive regulation of Rap GTPase activity (GO:0032854) | 2.98391786 |
| 102 | granulocyte activation (GO:0036230) | 2.98262623 |
| 103 | peptidyl-asparagine modification (GO:0018196) | 2.98256264 |
| 104 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.97811473 |
| 105 | myeloid cell activation involved in immune response (GO:0002275) | 2.95602946 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94799763 |
| 107 | response to host immune response (GO:0052572) | 2.94799763 |
| 108 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93711298 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 2.93043358 |
| 110 | T cell homeostasis (GO:0043029) | 2.92812142 |
| 111 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92698978 |
| 112 | activated T cell proliferation (GO:0050798) | 2.92602334 |
| 113 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.92189943 |
| 114 | negative T cell selection (GO:0043383) | 2.90202519 |
| 115 | negative thymic T cell selection (GO:0045060) | 2.89165533 |
| 116 | response to protozoan (GO:0001562) | 2.88724377 |
| 117 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88515192 |
| 118 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88515192 |
| 119 | mannose metabolic process (GO:0006013) | 2.88458930 |
| 120 | regulation of insulin secretion (GO:0050796) | 2.86678938 |
| 121 | B cell mediated immunity (GO:0019724) | 2.86094705 |
| 122 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86038791 |
| 123 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86038791 |
| 124 | B cell homeostasis (GO:0001782) | 2.83552091 |
| 125 | leukocyte degranulation (GO:0043299) | 2.82288594 |
| 126 | regulation of antigen processing and presentation (GO:0002577) | 2.81505854 |
| 127 | lymphocyte homeostasis (GO:0002260) | 2.79720735 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79038784 |
| 129 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.78191966 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.78169266 |
| 131 | response to host (GO:0075136) | 2.75278575 |
| 132 | response to host defenses (GO:0052200) | 2.75278575 |
| 133 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.75278575 |
| 134 | negative regulation of tissue remodeling (GO:0034104) | 2.74163053 |
| 135 | negative regulation of interleukin-6 production (GO:0032715) | 2.73691077 |
| 136 | cellular response to vitamin D (GO:0071305) | 2.73163887 |
| 137 | leukocyte aggregation (GO:0070486) | 2.73088237 |
| 138 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72947547 |
| 139 | negative regulation of innate immune response (GO:0045824) | 2.71061562 |
| 140 | megakaryocyte development (GO:0035855) | 2.70920766 |
| 141 | protein N-linked glycosylation (GO:0006487) | 2.70139419 |
| 142 | T cell receptor signaling pathway (GO:0050852) | 2.67643783 |
| 143 | ER overload response (GO:0006983) | 2.67138486 |
| 144 | positive regulation of peptide hormone secretion (GO:0090277) | 2.64119619 |
| 145 | response to unfolded protein (GO:0006986) | 2.63758342 |
| 146 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.63665344 |
| 147 | negative regulation of phagocytosis (GO:0050765) | 2.60659995 |
| 148 | regulation of peptide hormone secretion (GO:0090276) | 2.56579973 |
| 149 | positive regulation of regulated secretory pathway (GO:1903307) | 2.56508873 |
| 150 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56458743 |
| 151 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.53619333 |
| 152 | regulation of peptide secretion (GO:0002791) | 2.53035692 |
| 153 | response to topologically incorrect protein (GO:0035966) | 2.50323808 |
| 154 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.50262723 |
| 155 | positive regulation of peptide secretion (GO:0002793) | 2.49914114 |
| 156 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.49826436 |
| 157 | Golgi organization (GO:0007030) | 2.47423140 |
| 158 | gland morphogenesis (GO:0022612) | 2.47413433 |
| 159 | Peyers patch development (GO:0048541) | 2.46294368 |
| 160 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.46294368 |
| 161 | intestinal epithelial cell development (GO:0060576) | 2.45289583 |
| 162 | regulation of Rap GTPase activity (GO:0032317) | 2.41638161 |
| 163 | hepatocyte apoptotic process (GO:0097284) | 2.41609314 |
| 164 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.40860661 |
| 165 | protein autoprocessing (GO:0016540) | 2.39087959 |
| 166 | epithelial cell fate commitment (GO:0072148) | 2.36941027 |
| 167 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.36813925 |
| 168 | T cell migration (GO:0072678) | 2.36441187 |
| 169 | protein targeting to Golgi (GO:0000042) | 2.35796620 |
| 170 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.35744557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.70491256 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.19456403 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.83284938 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.80168739 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37449268 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.33053111 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.10199182 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04874093 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.73409160 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70679391 |
| 11 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.56626397 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55894913 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.49548214 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44342813 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.43678209 |
| 16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.43526561 |
| 17 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.39668848 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37824245 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.27951056 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.23506419 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20741727 |
| 22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.19457587 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.18660093 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.16127717 |
| 25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13569247 |
| 26 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.08677175 |
| 27 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.05459054 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03943718 |
| 29 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99994021 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97905991 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.97586586 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97353003 |
| 33 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.96120237 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86974213 |
| 35 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85599790 |
| 36 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85204602 |
| 37 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85192452 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82006015 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78193903 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75245848 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75070786 |
| 42 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.74796026 |
| 43 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.68359102 |
| 44 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67722189 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62873400 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61736068 |
| 47 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61644301 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56056401 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54207002 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51855186 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51529662 |
| 52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51141318 |
| 53 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.48267453 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46029376 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44109753 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42252517 |
| 57 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.42244289 |
| 58 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40644331 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38037963 |
| 60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38023857 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36696677 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35738972 |
| 63 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35484986 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34465301 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34034475 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32196405 |
| 67 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32174593 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29360910 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28742984 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27594108 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26010995 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25662121 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.25559888 |
| 74 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24561939 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23540909 |
| 76 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.19395686 |
| 77 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19131477 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17689215 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 1.17037842 |
| 80 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16143743 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15661243 |
| 82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15033364 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14374296 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12358928 |
| 85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11692900 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11063736 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10289020 |
| 88 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08096590 |
| 89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07638886 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07574248 |
| 91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.07534989 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07331985 |
| 93 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.06317448 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05233232 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03900024 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03602279 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01965149 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01538992 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01473823 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01347132 |
| 101 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00573018 |
| 102 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00257438 |
| 103 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.98458436 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97728295 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97359899 |
| 106 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97271298 |
| 107 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95971129 |
| 108 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95399967 |
| 109 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93640362 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92954203 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92633004 |
| 112 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91980286 |
| 113 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91709232 |
| 114 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91281419 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91251452 |
| 116 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91017590 |
| 117 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.90795162 |
| 118 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89932752 |
| 119 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89526927 |
| 120 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.87477268 |
| 121 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87410566 |
| 122 | P300_27268052_Chip-Seq_Bcells_Human | 0.86711106 |
| 123 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85454670 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85151831 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84730434 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84393659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.43768699 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.49988365 |
| 3 | MP0002693_abnormal_pancreas_physiology | 3.38383683 |
| 4 | MP0002909_abnormal_adrenal_gland | 3.10739725 |
| 5 | MP0003283_abnormal_digestive_organ | 3.06581608 |
| 6 | MP0003183_abnormal_peptide_metabolism | 2.89239503 |
| 7 | MP0001944_abnormal_pancreas_morphology | 2.76024302 |
| 8 | MP0003866_abnormal_defecation | 2.71196490 |
| 9 | MP0001790_abnormal_immune_system | 2.55143144 |
| 10 | MP0005387_immune_system_phenotype | 2.55143144 |
| 11 | MP0003303_peritoneal_inflammation | 2.43242240 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.38995437 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.36823512 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.36276697 |
| 15 | MP0000685_abnormal_immune_system | 2.32376623 |
| 16 | MP0001800_abnormal_humoral_immune | 2.29844112 |
| 17 | MP0004043_abnormal_pH_regulation | 2.22480018 |
| 18 | MP0005671_abnormal_response_to | 2.14513888 |
| 19 | MP0000013_abnormal_adipose_tissue | 2.12545850 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.10437422 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.02144357 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 1.98819074 |
| 23 | MP0008961_abnormal_basal_metabolism | 1.97460998 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.96077444 |
| 25 | MP0005220_abnormal_exocrine_pancreas | 1.86272077 |
| 26 | MP0005310_abnormal_salivary_gland | 1.86025211 |
| 27 | MP0004381_abnormal_hair_follicle | 1.85666121 |
| 28 | MP0006054_spinal_hemorrhage | 1.83523798 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.83004839 |
| 30 | MP0002398_abnormal_bone_marrow | 1.80432975 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.79248216 |
| 32 | MP0001819_abnormal_immune_cell | 1.78928329 |
| 33 | MP0005379_endocrine/exocrine_gland_phen | 1.77289312 |
| 34 | MP0002723_abnormal_immune_serum | 1.76232169 |
| 35 | MP0006082_CNS_inflammation | 1.72877221 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.72234140 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.68823534 |
| 38 | MP0001873_stomach_inflammation | 1.64956585 |
| 39 | MP0005451_abnormal_body_composition | 1.62440757 |
| 40 | MP0002928_abnormal_bile_duct | 1.60245758 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.60138038 |
| 42 | MP0003436_decreased_susceptibility_to | 1.59368575 |
| 43 | MP0000716_abnormal_immune_system | 1.58265943 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.57612439 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 1.56440086 |
| 46 | MP0002132_abnormal_respiratory_system | 1.55263663 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.52209486 |
| 48 | MP0008260_abnormal_autophagy | 1.50588348 |
| 49 | MP0004947_skin_inflammation | 1.48437856 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.42945726 |
| 51 | MP0008004_abnormal_stomach_pH | 1.42828676 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.41657268 |
| 53 | MP0005025_abnormal_response_to | 1.41263699 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.40512054 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.40512054 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.39563721 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.38267189 |
| 58 | MP0002009_preneoplasia | 1.36344244 |
| 59 | MP0002722_abnormal_immune_system | 1.34373284 |
| 60 | MP0000003_abnormal_adipose_tissue | 1.33812615 |
| 61 | MP0003045_fibrosis | 1.33403172 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.33243443 |
| 63 | MP0002405_respiratory_system_inflammati | 1.30187622 |
| 64 | MP0002429_abnormal_blood_cell | 1.30142274 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.29262823 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.29031625 |
| 67 | MP0001765_abnormal_ion_homeostasis | 1.27845624 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.27768008 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.25316764 |
| 70 | MP0003195_calcinosis | 1.25041862 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.24965982 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.23690207 |
| 73 | MP0002419_abnormal_innate_immunity | 1.19063483 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.17889588 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.17803649 |
| 76 | MP0001851_eye_inflammation | 1.16518944 |
| 77 | MP0000858_altered_metastatic_potential | 1.15270785 |
| 78 | MP0000490_abnormal_crypts_of | 1.13976359 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.12734199 |
| 80 | MP0009785_altered_susceptibility_to | 1.07280429 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.02613710 |
| 82 | MP0009278_abnormal_bone_marrow | 1.02499987 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.98953799 |
| 84 | MP0003828_pulmonary_edema | 0.98633663 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.97211838 |
| 86 | MP0000462_abnormal_digestive_system | 0.95877723 |
| 87 | MP0002933_joint_inflammation | 0.92859098 |
| 88 | MP0003868_abnormal_feces_composition | 0.91975789 |
| 89 | MP0004510_myositis | 0.90750693 |
| 90 | MP0002006_tumorigenesis | 0.89468213 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.85772322 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.85265461 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.84370772 |
| 94 | MP0003953_abnormal_hormone_level | 0.82354892 |
| 95 | MP0001853_heart_inflammation | 0.82180283 |
| 96 | MP0009764_decreased_sensitivity_to | 0.81163669 |
| 97 | MP0005166_decreased_susceptibility_to | 0.80525483 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.80271096 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.79377236 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.78186258 |
| 101 | MP0003724_increased_susceptibility_to | 0.75105136 |
| 102 | MP0000613_abnormal_salivary_gland | 0.73789109 |
| 103 | MP0000015_abnormal_ear_pigmentation | 0.72909983 |
| 104 | MP0003795_abnormal_bone_structure | 0.72419216 |
| 105 | MP0009840_abnormal_foam_cell | 0.71981951 |
| 106 | MP0000470_abnormal_stomach_morphology | 0.71824381 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.71175617 |
| 108 | MP0003693_abnormal_embryo_hatching | 0.70950831 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.70844342 |
| 110 | MP0001270_distended_abdomen | 0.70384329 |
| 111 | MP0010307_abnormal_tumor_latency | 0.69296182 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.66601222 |
| 113 | MP0008469_abnormal_protein_level | 0.66547840 |
| 114 | MP0001663_abnormal_digestive_system | 0.66525384 |
| 115 | MP0003787_abnormal_imprinting | 0.66096615 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.65820174 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.65533341 |
| 118 | MP0004883_abnormal_blood_vessel | 0.64910399 |
| 119 | MP0009763_increased_sensitivity_to | 0.64822666 |
| 120 | MP0001849_ear_inflammation | 0.64575470 |
| 121 | MP0003943_abnormal_hepatobiliary_system | 0.64152481 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.63232282 |
| 123 | MP0003959_abnormal_lean_body | 0.62774320 |
| 124 | MP0002019_abnormal_tumor_incidence | 0.62692652 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.61773537 |
| 126 | MP0003075_altered_response_to | 0.60215685 |
| 127 | MP0008874_decreased_physiological_sensi | 0.58841795 |
| 128 | MP0000609_abnormal_liver_physiology | 0.56141792 |
| 129 | MP0009931_abnormal_skin_appearance | 0.55834876 |
| 130 | MP0005390_skeleton_phenotype | 0.55814691 |
| 131 | MP0009115_abnormal_fat_cell | 0.54173493 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.53390273 |
| 133 | MP0005083_abnormal_biliary_tract | 0.52862029 |
| 134 | MP0005409_darkened_coat_color | 0.52690067 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.52010553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.40527642 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.09633573 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.95335669 |
| 4 | Symptomatic seizures (HP:0011145) | 4.48404484 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.41068589 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.37851057 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.20029891 |
| 8 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.08166962 |
| 9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.08166962 |
| 10 | Prolonged bleeding time (HP:0003010) | 4.07997725 |
| 11 | Myositis (HP:0100614) | 3.98223199 |
| 12 | Obstructive lung disease (HP:0006536) | 3.79318493 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.79318493 |
| 14 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.77532999 |
| 15 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.77501493 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.68877876 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.61892222 |
| 18 | Stomatitis (HP:0010280) | 3.59103967 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.54886217 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.51301506 |
| 21 | Large for gestational age (HP:0001520) | 3.51126726 |
| 22 | IgM deficiency (HP:0002850) | 3.46776605 |
| 23 | Encephalitis (HP:0002383) | 3.42193572 |
| 24 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.40666337 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.40666337 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.38264699 |
| 27 | Recurrent skin infections (HP:0001581) | 3.36975688 |
| 28 | Recurrent viral infections (HP:0004429) | 3.35464054 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.27407251 |
| 30 | Decreased circulating renin level (HP:0003351) | 3.27307423 |
| 31 | Pustule (HP:0200039) | 3.24192524 |
| 32 | Orchitis (HP:0100796) | 3.24184418 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 3.24147693 |
| 34 | Inflammation of the large intestine (HP:0002037) | 3.22186793 |
| 35 | Dysostosis multiplex (HP:0000943) | 3.20316146 |
| 36 | Chronic otitis media (HP:0000389) | 3.14049997 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.12235873 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.12235873 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.12235873 |
| 40 | Colitis (HP:0002583) | 3.12042503 |
| 41 | Hyperglycemia (HP:0003074) | 3.11571940 |
| 42 | Late onset (HP:0003584) | 3.09675603 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 3.09405498 |
| 44 | Petechiae (HP:0000967) | 3.06567511 |
| 45 | Cellulitis (HP:0100658) | 3.04368428 |
| 46 | T lymphocytopenia (HP:0005403) | 3.03632159 |
| 47 | Papilledema (HP:0001085) | 3.03521079 |
| 48 | Epistaxis (HP:0000421) | 3.03217959 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.98355918 |
| 50 | Optic neuritis (HP:0100653) | 2.98355918 |
| 51 | Abnormality of T cells (HP:0002843) | 2.93513436 |
| 52 | Granulocytopenia (HP:0001913) | 2.91140183 |
| 53 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.87576416 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.86731834 |
| 55 | Gingivitis (HP:0000230) | 2.86508931 |
| 56 | Abnormal pancreas size (HP:0012094) | 2.84313636 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.83253742 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.78284577 |
| 59 | Bronchitis (HP:0012387) | 2.76501371 |
| 60 | Verrucae (HP:0200043) | 2.75754088 |
| 61 | Papilloma (HP:0012740) | 2.75754088 |
| 62 | Hypochromic anemia (HP:0001931) | 2.73619170 |
| 63 | Urticaria (HP:0001025) | 2.73482100 |
| 64 | Ketoacidosis (HP:0001993) | 2.67634819 |
| 65 | Thoracolumbar scoliosis (HP:0002944) | 2.67239557 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.65726606 |
| 67 | Insulin resistance (HP:0000855) | 2.63425810 |
| 68 | Meningitis (HP:0001287) | 2.63292482 |
| 69 | Gingival bleeding (HP:0000225) | 2.57403435 |
| 70 | Villous atrophy (HP:0011473) | 2.56418447 |
| 71 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.56418447 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.56087640 |
| 73 | B lymphocytopenia (HP:0010976) | 2.56087640 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 2.54366388 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.52715574 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.52266915 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.51969487 |
| 78 | Nasal polyposis (HP:0100582) | 2.50559040 |
| 79 | Leukocytosis (HP:0001974) | 2.47846718 |
| 80 | Prominent metopic ridge (HP:0005487) | 2.44614138 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 2.42066522 |
| 82 | Purpura (HP:0000979) | 2.38767632 |
| 83 | Chronic sinusitis (HP:0011109) | 2.38289683 |
| 84 | Viral hepatitis (HP:0006562) | 2.37731030 |
| 85 | Abnormality of renin-angiotensin system (HP:0000847) | 2.34728961 |
| 86 | Lymphopenia (HP:0001888) | 2.34630621 |
| 87 | Abnormality of the nasal mucosa (HP:0000433) | 2.34147096 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.32825522 |
| 89 | Increased IgM level (HP:0003496) | 2.32571447 |
| 90 | Hypokalemia (HP:0002900) | 2.31224648 |
| 91 | Limb hypertonia (HP:0002509) | 2.31013606 |
| 92 | Severe combined immunodeficiency (HP:0004430) | 2.28999983 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.28580289 |
| 94 | Hemoptysis (HP:0002105) | 2.26580159 |
| 95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26367982 |
| 96 | Hyperactive renin-angiotensin system (HP:0000841) | 2.26250141 |
| 97 | Severe short stature (HP:0003510) | 2.22860632 |
| 98 | Hypergammaglobulinemia (HP:0010702) | 2.21480012 |
| 99 | Hyperparathyroidism (HP:0000843) | 2.19099203 |
| 100 | Macroorchidism (HP:0000053) | 2.18961391 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.18299703 |
| 102 | Thrombocytosis (HP:0001894) | 2.17894368 |
| 103 | Slow saccadic eye movements (HP:0000514) | 2.17761821 |
| 104 | Recurrent abscess formation (HP:0002722) | 2.17035071 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.16151839 |
| 106 | Thyroiditis (HP:0100646) | 2.16137543 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14773626 |
| 108 | Microcytic anemia (HP:0001935) | 2.14715298 |
| 109 | Pulmonary embolism (HP:0002204) | 2.14332442 |
| 110 | Arterial thrombosis (HP:0004420) | 2.14019075 |
| 111 | Eosinophilia (HP:0001880) | 2.12227505 |
| 112 | Episodic fever (HP:0001954) | 2.11812614 |
| 113 | Keratoconjunctivitis (HP:0001096) | 2.09433396 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.06897992 |
| 115 | Skin ulcer (HP:0200042) | 2.05745707 |
| 116 | Hypoplasia of the thymus (HP:0000778) | 2.05296712 |
| 117 | Increased IgE level (HP:0003212) | 2.00045786 |
| 118 | Emphysema (HP:0002097) | 1.99153134 |
| 119 | Chronic diarrhea (HP:0002028) | 1.98688986 |
| 120 | 11 pairs of ribs (HP:0000878) | 1.98403236 |
| 121 | Lymphoma (HP:0002665) | 1.97117248 |
| 122 | Abnormality of the metopic suture (HP:0005556) | 1.96436115 |
| 123 | IgA deficiency (HP:0002720) | 1.95993195 |
| 124 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95466502 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95466502 |
| 126 | Unilateral renal agenesis (HP:0000122) | 1.94714523 |
| 127 | Recurrent bacterial skin infections (HP:0005406) | 1.94520963 |
| 128 | Sepsis (HP:0100806) | 1.92421256 |
| 129 | Abdominal distention (HP:0003270) | 1.92053960 |
| 130 | Seborrheic dermatitis (HP:0001051) | 1.91292715 |
| 131 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.90142987 |
| 132 | Malnutrition (HP:0004395) | 1.89764045 |
| 133 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88474154 |
| 134 | Recurrent pneumonia (HP:0006532) | 1.88459426 |
| 135 | Restrictive lung disease (HP:0002091) | 1.87743948 |
| 136 | Combined immunodeficiency (HP:0005387) | 1.87173288 |
| 137 | Skin rash (HP:0000988) | 1.87056549 |
| 138 | Irregular vertebral endplates (HP:0003301) | 1.86673815 |
| 139 | Hypercortisolism (HP:0001578) | 1.85826930 |
| 140 | Osteomyelitis (HP:0002754) | 1.85679842 |
| 141 | Increased cerebral lipofuscin (HP:0011813) | 1.84921270 |
| 142 | Exocrine pancreatic insufficiency (HP:0001738) | 1.84269850 |
| 143 | Abnormality of the pleura (HP:0002103) | 1.82371312 |
| 144 | Impaired platelet aggregation (HP:0003540) | 1.81853074 |
| 145 | Abnormal platelet function (HP:0011869) | 1.81853074 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.81689467 |
| 147 | Thin bony cortex (HP:0002753) | 1.78641549 |
| 148 | Abnormality of potassium homeostasis (HP:0011042) | 1.77215790 |
| 149 | Generalized aminoaciduria (HP:0002909) | 1.76135455 |
| 150 | Vasculitis (HP:0002633) | 1.75922305 |
| 151 | Missing ribs (HP:0000921) | 1.73821310 |
| 152 | Autoimmune thrombocytopenia (HP:0001973) | 1.71949013 |
| 153 | Vacuolated lymphocytes (HP:0001922) | 1.71669894 |
| 154 | Chest pain (HP:0100749) | 1.70739227 |
| 155 | Hyperkalemia (HP:0002153) | 1.70182523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 4.39882666 |
| 2 | INSRR | 4.18415131 |
| 3 | MAP4K1 | 4.01790167 |
| 4 | PRPF4B | 3.38355081 |
| 5 | TAOK3 | 3.31598385 |
| 6 | ERN1 | 3.21080756 |
| 7 | MAP3K10 | 2.83447986 |
| 8 | HIPK2 | 2.70393889 |
| 9 | TRIB3 | 2.62147346 |
| 10 | EEF2K | 2.56475250 |
| 11 | TNK2 | 2.33037354 |
| 12 | MAPK15 | 1.99293524 |
| 13 | BTK | 1.97759706 |
| 14 | FLT3 | 1.93687617 |
| 15 | SMG1 | 1.91227173 |
| 16 | JAK3 | 1.87730395 |
| 17 | ITK | 1.83046435 |
| 18 | ZAP70 | 1.79784430 |
| 19 | GRK6 | 1.75449093 |
| 20 | PTK6 | 1.69113640 |
| 21 | FRK | 1.58630462 |
| 22 | PKN2 | 1.53666753 |
| 23 | TYK2 | 1.51506807 |
| 24 | SIK3 | 1.51342457 |
| 25 | SCYL2 | 1.48942704 |
| 26 | SYK | 1.47881218 |
| 27 | JAK1 | 1.46377186 |
| 28 | IRAK3 | 1.42753168 |
| 29 | MAP3K2 | 1.42729134 |
| 30 | STK10 | 1.41512352 |
| 31 | PRKCH | 1.41404119 |
| 32 | MAP3K1 | 1.32845171 |
| 33 | EPHB1 | 1.28501354 |
| 34 | LRRK2 | 1.23594999 |
| 35 | FGFR4 | 1.22760342 |
| 36 | TEC | 1.21600062 |
| 37 | IRAK4 | 1.19645320 |
| 38 | CSK | 1.16626547 |
| 39 | MAP3K11 | 1.15269644 |
| 40 | FGFR3 | 1.12729263 |
| 41 | CDK12 | 1.08227243 |
| 42 | PRKD2 | 1.03981553 |
| 43 | JAK2 | 0.98834768 |
| 44 | EPHA3 | 0.97480536 |
| 45 | TESK2 | 0.95671726 |
| 46 | PDGFRA | 0.94984664 |
| 47 | SIK1 | 0.92427526 |
| 48 | ALK | 0.91965997 |
| 49 | BLK | 0.89437225 |
| 50 | LCK | 0.88939667 |
| 51 | DYRK1B | 0.87303157 |
| 52 | CDC42BPA | 0.85858200 |
| 53 | HCK | 0.84153901 |
| 54 | TXK | 0.83208681 |
| 55 | FES | 0.82899950 |
| 56 | SIK2 | 0.81287157 |
| 57 | MAPK12 | 0.78598522 |
| 58 | FGR | 0.78238283 |
| 59 | MARK3 | 0.78219695 |
| 60 | CSF1R | 0.77956509 |
| 61 | CAMKK2 | 0.75640624 |
| 62 | KSR2 | 0.75495845 |
| 63 | CDK4 | 0.75346865 |
| 64 | MATK | 0.74988420 |
| 65 | RIPK1 | 0.74335946 |
| 66 | PDPK1 | 0.74045592 |
| 67 | TBK1 | 0.73896085 |
| 68 | TAOK2 | 0.72667502 |
| 69 | NLK | 0.72530500 |
| 70 | BRSK2 | 0.70438260 |
| 71 | RIPK4 | 0.70204165 |
| 72 | CAMKK1 | 0.69792690 |
| 73 | BRD4 | 0.69684033 |
| 74 | LYN | 0.68471571 |
| 75 | BMPR2 | 0.67651841 |
| 76 | KIT | 0.66994225 |
| 77 | IKBKE | 0.66412789 |
| 78 | ICK | 0.65866949 |
| 79 | PTK2 | 0.65621183 |
| 80 | CHUK | 0.63728045 |
| 81 | MAP2K2 | 0.62739694 |
| 82 | YES1 | 0.62537065 |
| 83 | PRKD3 | 0.62424695 |
| 84 | EIF2AK3 | 0.62155825 |
| 85 | UHMK1 | 0.62116311 |
| 86 | MAP2K3 | 0.61231820 |
| 87 | IRAK2 | 0.58462969 |
| 88 | MAPK7 | 0.57443743 |
| 89 | MARK2 | 0.53716718 |
| 90 | FYN | 0.53032386 |
| 91 | RET | 0.52504350 |
| 92 | MAP3K14 | 0.51988671 |
| 93 | PDGFRB | 0.50803249 |
| 94 | PIM1 | 0.50395582 |
| 95 | RPS6KC1 | 0.50121976 |
| 96 | RPS6KL1 | 0.50121976 |
| 97 | TGFBR2 | 0.46861465 |
| 98 | MAP3K13 | 0.45380595 |
| 99 | IRAK1 | 0.44849632 |
| 100 | PRKD1 | 0.44645607 |
| 101 | CDK6 | 0.43935733 |
| 102 | RPS6KA2 | 0.43881893 |
| 103 | WNK4 | 0.42528500 |
| 104 | MAP3K7 | 0.42011127 |
| 105 | PDK1 | 0.41614701 |
| 106 | BMX | 0.41583927 |
| 107 | PRKCQ | 0.40671885 |
| 108 | WNK1 | 0.40297006 |
| 109 | RPS6KA4 | 0.39787784 |
| 110 | MAP3K6 | 0.39123057 |
| 111 | RPS6KA6 | 0.38844644 |
| 112 | TESK1 | 0.38243004 |
| 113 | NEK2 | 0.38182299 |
| 114 | MTOR | 0.36345392 |
| 115 | CDK9 | 0.35520452 |
| 116 | MAPKAPK3 | 0.35499676 |
| 117 | MAPK11 | 0.34848895 |
| 118 | SGK3 | 0.33881702 |
| 119 | MAP3K3 | 0.33792181 |
| 120 | CLK1 | 0.33524468 |
| 121 | MAP2K6 | 0.33480010 |
| 122 | RPS6KB2 | 0.32974643 |
| 123 | TAOK1 | 0.32380172 |
| 124 | MAPKAPK2 | 0.31903615 |
| 125 | CAMK1G | 0.31047085 |
| 126 | IKBKB | 0.30333819 |
| 127 | MAPK4 | 0.30024012 |
| 128 | STK11 | 0.29790073 |
| 129 | MAPK3 | 0.28799261 |
| 130 | PIK3CG | 0.28107955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.77187558 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.87639698 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.83286300 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.56509191 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.47052368 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41934448 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.37908793 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34030061 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.29371322 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26660215 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.06730090 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98137146 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78925256 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75063368 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.73265261 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70993189 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.53921216 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50257821 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40310096 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37700276 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37525230 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36022578 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.34393187 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30609423 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29535779 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28577665 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27876076 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23823507 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.22716232 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22453788 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.21440476 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18272136 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13875274 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12749995 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10319591 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10234375 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.07488703 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07058160 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05187395 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05009851 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03915973 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.01654820 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.01344190 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98337974 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 0.97839580 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95386650 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95067637 |
| 48 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.91532988 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89066895 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89030295 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88912430 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87893758 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85371364 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84606953 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82981832 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81688986 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81246806 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79745440 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79189423 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78828233 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.76835452 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75329492 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.74587940 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74400751 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.72632872 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71832373 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70480259 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69284625 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68861897 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68404484 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68276149 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66748669 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66416422 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65582737 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.65040508 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64945020 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63524791 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63194020 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63058622 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62274393 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61059361 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.61024899 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.60993715 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.60891817 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60682587 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59837462 |
| 87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59214062 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58656246 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58647322 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58161511 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57988446 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55839615 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55468505 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.54898941 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54816867 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52843223 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.52813972 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52691401 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51451294 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50693403 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50361867 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50063825 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49977651 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49201110 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49196340 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48933782 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47622162 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.46046002 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.45888423 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45671618 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45203506 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.44793836 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.44673348 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43311258 |
| 115 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42676695 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42414744 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41657635 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40365860 |
| 119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39957553 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39146862 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38962044 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38476692 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.38309944 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37615216 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37426995 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.37174709 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37100365 |

